229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Analyze DCF forecasts for the company and compare them with competitors.
391.04B
Revenue has increased from the previous period.
2.02%
Revenue growth rate has increased from the previous period.
134.66B
EBITDA has increased from the previous period.
34.44%
EBITDA margin has increased from the previous period.
123.22B
EBIT has increased from the previous period.
31.51%
EBIT margin has increased from the previous period.
11.45B
Depreciation has decreased from the previous period.
65.17B
Total cash has increased from the previous period.
16.67%
Cash percentage has increased from the previous period.
66.24B
Receivables have increased from the previous period.
16.94%
Receivables percentage has increased from the previous period.
7.29B
Inventories have increased from the previous period.
1.86%
Inventory percentage has increased from the previous period.
68.96B
Accounts payable has increased from the previous period.
17.64%
Payables percentage has increased from the previous period.
-9.45B
Capital expenditure has decreased from the previous period.
-2.42%
CapEx percentage has decreased from the previous period.
9.93%
WACC has decreased from the previous period.
10.11%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.24
Beta is unchanged from the previous period.
15.41B
Diluted shares outstanding is unchanged from the previous period.
106.63B
Total debt is unchanged from the previous period.
3.88T
Total equity is unchanged from the previous period.
3.98T
Total capital is unchanged from the previous period.
2.68%
Debt weighting is unchanged from the previous period.
97.32%
Equity weighting is unchanged from the previous period.
93.53B
EBIAT has decreased from the previous period.
95.67B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
2.73T
Terminal value is unchanged from the previous period.
2.19T
Enterprise value has increased from the previous period.
76.69B
Net debt is unchanged from the previous period.
2.11T
Equity value has increased from the previous period.
136.89
Equity value per share has increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$228.20
Analysts expect the stock price to decrease by 2.51%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
415.00B
The estimated revenue has increased from the previous period.
136.29B
The estimated EBITDA has increased from the previous period.
7.38
The estimated EPS has increased from the previous period.
113.17B
The estimated net income has increased from the previous period.
123.12B
The estimated EBIT has increased from the previous period.
27.23B
The estimated SG&A expenses have increased from the previous period.
